Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis

被引:447
作者
van Staa, T. P.
Geusens, P.
Bijlsma, J. W. J.
Leufkens, H. G. M.
Cooper, C.
机构
[1] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3508 TC Utrecht, Netherlands
[3] Gen Practice Res Database, London, England
[4] Univ Hosp, Maastricht, Netherlands
[5] Limburgs Univ Ctr, Diepenbeek, Belgium
[6] Univ Utrecht, Med Ctr, Utrecht, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 10期
基金
英国医学研究理事会;
关键词
D O I
10.1002/art.22117
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective. To determine whether patients with rheumatoid arthritis (RA) have an increased risk of fracture, and to estimate their long-term absolute fracture risk. Methods. We studied patients with RA ages 2:40 years in the British General Practice Research Database, each matched by age, sex, calendar time, and practice to 3 control patients. Incident fractures, as recorded in the computerized medical records, were ascertained over a median followup of 7.6 years. The fracture rate in RA patients compared with controls was adjusted for smoking, body mass index (BMI), and several clinical risk factors, and Cox proportional hazards models were used to calculate the relative risk (RR) of fracture in RA. A risk score was then developed to provide an estimate of the 5- and 10-year fracture risk among RA patients. Results. There were 30,262 patients with RA, of whom 2,460 experienced a fracture during followup. Compared with controls, patients with RA had an increased risk of fracture, which was most marked at the hip (RR 2.0, 95% confidence interval [95% CI] 1.8-2.3) and spine (RR 2.4, 95% CI 2.0-2.8). Indicators of a substantially elevated risk of fracture (at the hip) included > 10 years' duration of RA (RR 3.4, 95% CI 3.0-3.9), low BMI (RR 3.9, 95% CI 3.1-4.9), and use of oral glucocorticoids (RR 3.4, 95% CI 3.0-4.0). Modeling of the long-term risk profiles revealed that, for example, in a woman age 65 years with longstanding RA whose risk factors also included low BMI, a history of fracture, and frequent use of oral glucocorticoids, the 5-year risk of hip fracture was 5.7% (95% CI 5.3-6.1%). Conclusion. Patients with RA are at increased risk of osteoporotic fractures. This increased risk is attributable to a combination of disease activity and use of oral glucocorticoids.
引用
收藏
页码:3104 / 3112
页数:9
相关论文
共 36 条
[1]
[Anonymous], 1994, Pharmacoepidemiology) and Drug Safety
[2]
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[3]
Glucocorticoids in the treatment of early and late RA [J].
Bijlsma, JWJ ;
Boers, M ;
Saag, KG ;
Furst, DE .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1033-1037
[4]
COPPER C, 1995, ANN RHEUM DIS, V54, P49
[5]
Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis [J].
de Nijs, RNJ ;
Jacobs, JWG ;
Bijlsma, JWJ ;
Lems, WF ;
Laan, RFJM ;
Houben, HHM ;
ter Borg, EJ ;
Huisman, AM ;
Bruyn, GAW ;
van Oijen, PLM ;
Westgeest, AAA ;
Algra, A ;
Hofman, DM .
RHEUMATOLOGY, 2001, 40 (12) :1375-1383
[6]
The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database [J].
Edwards, CJ ;
Arden, NK ;
Fisher, D ;
Saperia, JC ;
Reading, I ;
Van Staa, TP ;
Cooper, C .
RHEUMATOLOGY, 2005, 44 (11) :1394-1398
[7]
Felsenberg D, 2002, J BONE MINER RES, V17, P716
[8]
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[9]
2-4
[10]
Harris Jr ED, 1993, TXB RHEUMATOLOGY, V1, P833